Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.400
+0.013 (3.36%)
Mar 9, 2026, 1:54 PM EDT - Market open
Jupiter Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | 0.23 | 0.64 | 1.13 | |
| Revenue Growth (YoY) | - | - | - | -63.44% | -43.35% | - | |
| Cost of Revenue | 2.24 | 0.49 | 0.95 | 0.94 | 1.45 | 1.64 | |
| Gross Profit | -2.24 | -0.49 | -0.95 | -0.71 | -0.81 | -0.52 | |
| Selling, General & Admin | 5.31 | 2.6 | 2.92 | 2.72 | 3.1 | 1.34 | |
| Operating Expenses | 5.31 | 2.6 | 2.92 | 2.72 | 3.1 | 1.34 | |
| Operating Income | -7.56 | -3.09 | -3.87 | -3.43 | -3.91 | -1.85 | |
| Interest Expense | -0.03 | -0.25 | -0.22 | -0.74 | -0.11 | -0.01 | |
| Interest & Investment Income | 0.04 | 0.01 | 0 | 0 | 0 | 0 | |
| Other Non Operating Income (Expenses) | 0.05 | 0.04 | 0.19 | 0.26 | -0.09 | 0.28 | |
| EBT Excluding Unusual Items | -7.5 | -3.3 | -3.9 | -3.91 | -4.11 | -1.58 | |
| Other Unusual Items | -0.09 | 0.86 | -0.89 | -1.05 | -0.09 | -0.07 | |
| Pretax Income | -7.6 | -2.44 | -4.78 | -4.96 | -4.2 | -1.65 | |
| Net Income | -7.6 | -2.44 | -4.78 | -4.96 | -4.2 | -1.65 | |
| Net Income to Common | -7.6 | -2.44 | -4.78 | -4.96 | -4.2 | -1.65 | |
| Shares Outstanding (Basic) | 33 | 29 | 26 | 25 | 24 | 22 | |
| Shares Outstanding (Diluted) | 33 | 29 | 26 | 25 | 24 | 22 | |
| Shares Change (YoY) | 20.07% | 9.01% | 3.75% | 6.69% | 9.51% | 5.01% | |
| EPS (Basic) | -0.23 | -0.08 | -0.18 | -0.19 | -0.18 | -0.08 | |
| EPS (Diluted) | -0.23 | -0.08 | -0.18 | -0.19 | -0.18 | -0.08 | |
| Gross Margin | - | - | - | - | -126.90% | -45.74% | |
| Operating Margin | - | - | - | -1471.38% | -612.36% | -164.41% | |
| Profit Margin | - | - | - | -2125.15% | -658.31% | -146.92% | |
| EBIT | -7.56 | -3.09 | -3.87 | -3.43 | -3.91 | -1.85 | |
| EBIT Margin | - | - | - | - | - | -164.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.